Last reviewed · How we verify

NCT04345549

Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak

Completed NA Last updated 14 April 2020
What this trial tests

NA trial testing Individualised Ayurveda in Flu Like Symptom in 18 participants. Completed in 30 March 2020.

Timeline
26 February 2020
Primary endpoint
30 March 2020
30 March 2020

Quick facts

Lead sponsorAarogyam UK
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment18
Start date26 February 2020
Primary completion30 March 2020
Estimated completion30 March 2020
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Aarogyam UK — full company profile →

Who can join

Adults 18 to 60, any sex, with Flu Like Symptom or Flu Like Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

From the end of January 2020, Coronavirus disease 2019 began to spread in United Kingdom (UK). During the same time, seasonal flu continued to circulate across the UK. With similar course of management at early stages, flu like symptoms were self-isolated to prevent the spread and further complications of infection. Present study aimed to evaluate the effect of self-managed Ayurveda on flu like symptoms in people who self-isolated at home for 7-days in March 2020 during the Covid-19 outbreak in UK.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions.
    Alam S, Sarker MMR, Afrin S, Richi FT, et al · · 2021 · cited 61× · PMID 34122096 · DOI 10.3389/fphar.2021.671498
  2. Antiviral and Immunomodulatory Effects of Phytochemicals from Honey against COVID-19: Potential Mechanisms of Action and Future Directions.
    Al-Hatamleh MAI, Hatmal MM, Sattar K, Ahmad S, et al · · 2020 · cited 55× · PMID 33138197 · DOI 10.3390/molecules25215017
  3. Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review.
    Singh RS, Singh A, Kaur H, Batra G, et al · · 2021 · cited 22× · PMID 34132429 · DOI 10.1002/ptr.7150
  4. Possible Potential Effects of Honey and Its Main Components Against Covid-19 Infection.
    Abedi F, Ghasemi S, Farkhondeh T, Azimi-Nezhad M, et al · · 2021 · cited 20× · PMID 33867892 · DOI 10.1177/1559325820982423
  5. A Comprehensive Summary of the Knowledge on COVID-19 Treatment.
    Peng Y, Tao H, Satyanarayanan SK, Jin K, et al · · 2021 · cited 18× · PMID 33532135 · DOI 10.14336/ad.2020.1124
  6. An exhaustive comprehension of the role of herbal medicines in Pre- and Post-COVID manifestations.
    Prajapati SK, Malaiya A, Mishra G, Jain D, et al · · 2022 · cited 11× · PMID 35654349 · DOI 10.1016/j.jep.2022.115420
  7. SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments.
    Wang X, Li J, Liu H, Hu X, et al · · 2023 · cited 7× · PMID 36985154 · DOI 10.3390/microorganisms11030580
  8. COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2.
    Deshmukh R, Harwansh RK, Garg A, Mishra S, et al · · 2024 · cited 5× · PMID 38751601 · DOI 10.2174/0113892029291098240129113500

Verify or expand the search:

Other Aarogyam UK trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04345549.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing